Geliang Yang
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
Papers in
-
- Natural product bioactivities and synthesis 2
-
- Complementary and Alternative Medicine Studies 4
- Acupuncture Treatment Research Studies 2
- Herbal Medicine Research Studies 2
- Co-authors
- Huiqing Zhang (9 shared papers)Wei Zhang (2 shared papers)Ruixiang Song (1 shared paper)Qi Chen (1 shared paper)Teng‐Yun Wu (1 shared paper)Lin Zhao (1 shared paper)Yufei Yang (3 shared papers)Changquan Ling (10 shared papers)
- Journals
- Integrative Cancer Therapies (5 papers)Oncotarget (3 papers)Journal of Semiconductors (2 papers)BMJ Open (1 paper)IEEE Transactions on Circuits & Systems II Express Briefs (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Geliang Yang
21 papers receiving 279 citations
Peers
Comparison fields: 5 of 87
- Clinical Biochemistry 45
- Drug Discovery 1
- Complementary and alternative medicine 36
- Statistics, Probability and Uncertainty 19
- Oncology 63
Countries citing papers authored by Geliang Yang
This map shows the geographic impact of Geliang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geliang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geliang Yang more than expected).
Fields of papers citing papers by Geliang Yang
This network shows the impact of papers produced by Geliang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geliang Yang. The network helps show where Geliang Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Geliang Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 105 | |
| 2 | 2020 | 36 | |
| 3 | 2017 | 22 | |
| 4 | 2013 | 20 | |
| 5 | 2017 | 19 | |
| 6 | 2017 | 16 | |
| 7 | 2022 | 12 | |
| 8 | 2023 | 10 | |
| 9 | 2020 | 9 | |
| 10 | 2016 | 7 | |
| 11 | 2018 | 7 | |
| 12 | 2016 | 5 | |
| 13 | 2017 | 3 | |
| 14 | 2018 | 3 | |
| 15 | 2015 | 3 | |
| 16 | 2016 | 2 | |
| 17 | 2012 | 2 | |
| 18 | 2018 | 2 | |
| 19 | 2014 | 1 | |
| 20 | 2021 | 1 |
About Geliang Yang
Geliang Yang is a scholar working on Molecular Biology, Complementary and alternative medicine, Electrical and Electronic Engineering, Oncology and Pharmacology, having authored 23 papers that have together received 286 indexed citations. Recurring topics across this work include Radio Frequency Integrated Circuit Design (4 papers), Complementary and Alternative Medicine Studies (4 papers), Meta-analysis and systematic reviews (3 papers), Natural product bioactivities and synthesis (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Acupuncture Treatment Research Studies (2 papers), Herbal Medicine Research Studies (2 papers) and Pharmacological Effects of Natural Compounds (2 papers). The work is most often cited by research in Clinical Biochemistry (45 citations), Drug Discovery (1 citation), Complementary and alternative medicine (36 citations), Statistics, Probability and Uncertainty (19 citations) and Oncology (63 citations). Geliang Yang has collaborated with scholars based in China and United States. Frequent co-authors include Huiqing Zhang, Wei Zhang, Ruixiang Song, Qi Chen, Teng‐Yun Wu, Lin Zhao, Yufei Yang, Changquan Ling, Yonghua Su and Wei Gu. Their work appears in journals such as Integrative Cancer Therapies, Oncotarget, Journal of Semiconductors, BMJ Open and IEEE Transactions on Circuits & Systems II Express Briefs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.